相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pioglitazone enhances the blood pressure-lowering effect of losartan via synergistic attenuation of angiotensin II-induced vasoconstriction
Xiang Kong et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2014)
Reciprocal Relationship Between Reactive Oxygen Species and Cyclooxygenase-2 and Vascular Dysfunction in Hypertension
Sonia Martinez-Revelles et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Pioglitazone ameliorates systolic and diastolic cardiac dysfunction in rat model of angiotensin II-induced hypertension
Aiko Sakamoto et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Effects of PPARγ Agonist Pioglitazone on Redox-Sensitive Cellular Signaling in Young Spontaneously Hypertensive Rats
Ima Dovinova et al.
PPAR RESEARCH (2013)
Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function
Raquel Hernanz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Endothelin in hypertension: an update
Yohann Rautureau et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2012)
Pioglitazone induces regression and stabilization of coronary atherosclerotic plaques in patients with impaired glucose tolerance
H. -B. Yang et al.
DIABETIC MEDICINE (2012)
Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension
Manuel Gomez-Guzman et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress
Angela Martin et al.
JOURNAL OF HYPERTENSION (2012)
ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy
Suko Adiarto et al.
LIFE SCIENCES (2012)
Endothelin-1 gene regulation
Lisa R. Stow et al.
FASEB JOURNAL (2011)
ETA Activation Mediates Angiotensin II-Induced Infiltration of Renal Cortical T Cells
Erika I. Boesen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Role of endothelin in the cardiovascular system
Fernando Rodriguez-Pascual et al.
PHARMACOLOGICAL RESEARCH (2011)
A Novel and Specific NADPH Oxidase-1 (Nox1) Small-Molecule Inhibitor Blocks the Formation of Functional Invadopodia in Human Colon Cancer Cells
Davide Gianni et al.
ACS CHEMICAL BIOLOGY (2010)
Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-κB in human aortic smooth muscle cells
Adrian Manea et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Oral Intake of Rosiglitazone Promotes a Central Antihypertensive Effect Via Upregulation of Peroxisome Proliferator-Activated Receptor-γ and Alleviation of Oxidative Stress in Rostral Ventrolateral Medulla of Spontaneously Hypertensive Rats
Samuel H. H. Chan et al.
HYPERTENSION (2010)
Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts
Tzu-Hurng Cheng et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Endothelin-1 (ET-1) Increases the Expression of Remodeling Genes in Vascular Smooth Muscle through Linked Calcium and cAMP Pathways ROLE OF A PHOSPHOLIPASE A2(cPLA2)/CYCLOOXYGENASE-2 (COX-2)/PROSTACYCLIN RECEPTOR-DEPENDENT AUTOCRINE LOOP
Karl Deacon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Impaired Peroxisome Proliferator-activated Receptor-γ Contributes to Phenotypic Modulation of Vascular Smooth Muscle Cells during Hypertension
Lili Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Downregulating osteopontin reduces angiotensin II-induced inflammatory activation in vascular smooth muscle cells
B. L. Yin et al.
INFLAMMATION RESEARCH (2009)
p38 MAPK contributes to angiotensin II-induced COX-2 expression in aortic fibroblasts from normotensive and hypertensive rats
Amada E. Beltran et al.
JOURNAL OF HYPERTENSION (2009)
AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells role of p22phox subunit
Adrian Manea et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme: Possible involvement of the ERK1/2-JunB pathway
Muhammer Ozgur Cevik et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats
Y. Alvarez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Endothelin: 20 years from discovery to therapy
Matthias Barton et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2008)
Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts
Jia Zhang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production
Sergey I. Dikalov et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Upregulation of cortical COX-2 in salt-sensitive hypertension: Role of angiotensin II and reactive oxygen species
Edgar A. Jaimes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
PPARs and molecular mechanisms of transrepression
Mercedes Ricote et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Mechanisms underlying the chronic pioglitazone treatment-induced improvement in the impaired endothelium-dependent relaxation seen in aortas from diabetic rats
Takayuki Matsumoto et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats
Yolanda Alvarez et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Inhibitory effects of PPAR-γ on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats
Augusto C. Montezano et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2007)
Treatment of spontaneously hypertensive rats with rosiglitazone and/or enalapril restores balance between vasodilator and vasoconstrictor actions of insulin with simultaneous improvement in hypertension and insulin resistance
Maria A. Potenza et al.
DIABETES (2006)
Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications
Rhian M. Touyz et al.
VASCULAR PHARMACOLOGY (2006)
Renal and vascular hypertension-induced inflammation:: role of angiotensin II
M Ruiz-Ortega et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2006)
Modulation of the oxidative stress and inflammatory response by PPAR-γ agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion
M Collino et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats
M Sánchez-Hidalgo et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses
Y Alvarez et al.
JOURNAL OF HYPERTENSION (2005)
Endothelin mediates superoxide production in angiotensin II-induced hypertension in rats
MA Lapante et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention
KS Chun et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Role of reactive oxygen species-sensitive extracellular signal-regulated kinase pathway in angiotensin II-induced endothelin-1 gene expression in vascular endothelial cells
YH Hsu et al.
JOURNAL OF VASCULAR RESEARCH (2004)
Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells
HJ Hong et al.
CARDIOVASCULAR RESEARCH (2004)
Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts
TH Cheng et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Endothelin-A receptors mediate renal hemodynamic effects of exogenous angiotensin II in humans
A Montanari et al.
HYPERTENSION (2003)
Endothelin-A receptors mediate renal hemodynamic effects of exogenous angiotensin II in humans
A Montanari et al.
HYPERTENSION (2003)
Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells - Potential role in diabetic nephropathy
S Kiritoshi et al.
DIABETES (2003)
Peroxisome proliferator-activated receptor-γ activators inhibit endothelin-1-related cardiac hypertrophy in rats
S Sakai et al.
CLINICAL SCIENCE (2002)
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats -: Role of peroxisome proliferator-activated receptor-γ
QN Diep et al.
CIRCULATION (2002)
PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts
MA Simonin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
被撤回的出版物: Peroxisome proliferator-activated receptor γ ligands suppress the transcriptional activation of cyclooxygenase-2 -: Evidence for involvement of activator protein-1 and CREB-binding protein/p300 (Retracted article. See vol. 295, pg. 291, 2020)
K Subbaramaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Angiotensin II activates nuclear transcription factor-kappa B in aorta of normal rats and in vascular smooth muscle cells of AT(1) knockout mice
M Ruiz-Ortega et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
Endothelin 1 transcription is controlled by nuclear factor-kappa B in AGE-stimulated cultured endothelial cells
P Quehenberger et al.
DIABETES (2000)
分享论文
